Nevertheless, the tumors deficient for Smad4 retained epithelial differentiation and manifested an attenuated metastatic potential (Bardeesy et al., 2006b; Whittle et al., 2015), which is also in favor of a tumor promoter role of TGF-β signaling. Here, SMAD4 is linked to neoplasm.